Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)

PHASE2RecruitingINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

August 19, 2022

Primary Completion Date

October 1, 2027

Study Completion Date

October 1, 2027

Conditions
Small-cell Lung CancerExtensive-stage Small-cell Lung CancerLung Cancer
Interventions
RADIATION

Ablative Radiation

Ablative radiation therapy is a highly focused radiation treatment that gives an intense dose of radiation concentrated on a tumor or very specific area of the body, while limiting the radiation that affects surrounding organs.

DRUG

Durvalumab

Durvalumab is an immunotherapy drug -- a drug used to help boost your immune response to fight cancer.

DRUG

Etoposide

Etoposide is a chemotherapy drug approved for different kinds of cancer, including small cell lung cancer.

DRUG

Carboplatin

Carboplatin is a chemotherapy drug approved for different kinds of cancer, including small cell lung cancer.

Trial Locations (2)

53792

ACTIVE_NOT_RECRUITING

University of Wisconsin Carbone Cancer Center, Madison

60637

RECRUITING

University of Chicago Medicine, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER